CD133 induces tumour-initiating properties in HEK293 cells

Martin Canis(Ludwig-Maximilians-Universität München), Olivier Gires(Ludwig-Maximilians-Universität München)

Tumor Biology

November 12, 2012

10.1007/s13277-012-0568-z

Cited by 23

Related Papers

EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers

|PLoS Biology|2018|97

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma

|Scientific Reports|2018|44

SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival

|Molecular Oncology|2021|28